The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors

Jan Korbecki,Mateusz Bosiacki,Iwona Szatkowska,Patrycja Kupnicka,Dariusz Chlubek,Irena Baranowska-Bosiacka
DOI: https://doi.org/10.3390/ijms25084365
IF: 5.6
2024-04-16
International Journal of Molecular Sciences
Abstract:Chemokines play a key role in cancer processes, with CXCL1 being a well-studied example. Due to the lack of a complete summary of CXCL1's role in cancer in the literature, in this study, we examine the significance of CXCL1 in various cancers such as bladder, glioblastoma, hemangioendothelioma, leukemias, Kaposi's sarcoma, lung, osteosarcoma, renal, and skin cancers (malignant melanoma, basal cell carcinoma, and squamous cell carcinoma), along with thyroid cancer. We focus on understanding how CXCL1 is involved in the cancer processes of these specific types of tumors. We look at how CXCL1 affects cancer cells, including their proliferation, migration, EMT, and metastasis. We also explore how CXCL1 influences other cells connected to tumors, like promoting angiogenesis, recruiting neutrophils, and affecting immune cell functions. Additionally, we discuss the clinical aspects by exploring how CXCL1 levels relate to cancer staging, lymph node metastasis, patient outcomes, chemoresistance, and radioresistance.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to summarize the clinical significance of the chemokine CXCL1 in various tumors and its role in molecular cancer processes. Specifically, the paper explores the role of CXCL1 in the following types of tumors: 1. **Bladder Cancer**: - CXCL1 expression is elevated in bladder cancer and is associated with tumor progression, cell proliferation, migration, and epithelial-mesenchymal transition (EMT). - CXCL1 also participates in the recruitment of tumor-associated neutrophils (TAN) and myeloid-derived suppressor cells (MDSC), leading to immune evasion. - The level of CXCL1 in urine may serve as a diagnostic marker for bladder cancer. 2. **Glioblastoma**: - CXCL1 expression in glioblastoma can be elevated or unchanged, but it is higher than in lower-grade gliomas. - CXCL1 promotes the proliferation and migration of glioblastoma cells and increases the expression of programmed death-ligand 1 (PD-L1), enhancing immune evasion. - CXCL1 also leads to resistance to radiotherapy and temozolomide (TMZ) chemotherapy. 3. **Hemangioendothelioma**: - CXCL1 expression is elevated in hemangioendothelioma, primarily mediated through the NF-κB pathway. - Although CXCL1 does not directly affect cell proliferation, it induces cell migration and is involved in tumor growth and angiogenesis. 4. **Hematolymphoid Tumors**: - In acute myeloid leukemia (AML), CXCL1 expression is elevated and is associated with poorer overall survival. - CXCL1 is related to the proliferation of AML cells and is upregulated under hypoxic conditions, having a pro-angiogenic effect. In summary, the main purpose of the paper is to comprehensively summarize the mechanisms of action of CXCL1 in various cancers and to explore its potential as a therapeutic target.